Skip to main content

Table 2 Effect of YGMM on ALT, AST, TG and TB levels in control and alcohol-treated rats

From: Evaluation of the hepatoprotective effect of Yigan mingmu oral liquid against acute alcohol-induced liver injury in rats

Group ALT (U/l) AST (U/l) TG (mg/dl) TB (mg/dl) AST/ALT
Control 8.49 ± 0.33 21.70 ± 1.10 3.75 ± 0.56 0.28 ± 0.02 2.57 ± 0.15
Alcohol 11.37 ± 0.37## 31.28 ± 1.95### 10.50 ± 2.14## 0.47 ± 0.04### 2.77 ± 0.23
Silymarin 8.09 ± 0.47** 24.16 ± 3.56* 2.67 ± 0.61*** 0.32 ± 0.03** 3.03 ± 0.55
YGMM (low dose) 9.35 ± 1.12 22.24 ± 2.23** 3.08 ± 1.09** 0.33 ± 0.03** 2.41 ± 0.13
YGMM (medium dose) 8.34 ± 1.44* 19.79 ± 0.58*** 4.77 ± 1.42* 0.26 ± 0.06*** 2.52 ± 0.43
YGMM (high dose) 8.56 ± 0.41* 18.50 ± 1.88*** 4.89 ± 1.80* 0.26 ± 0.01*** 2.15 ± 0.14
  1. Data are presented as mean ± SEM in each group. Statistically significant differences are indicated by asterisks and pound sign (*p < 0.05, **p < 0.01, ***p < 0.001 compared with the model group; ##p < 0.01, ###p < 0.001 compared with the control group)